000 | 01139 a2200325 4500 | ||
---|---|---|---|
005 | 20250516071837.0 | ||
264 | 0 | _c20120606 | |
008 | 201206s 0 0 eng d | ||
022 | _a1874-4729 | ||
024 | 7 |
_a10.2174/1874471011104030197 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOlafsen, Tove | |
245 | 0 | 0 |
_aProtein targeting constructs in alpha therapy. _h[electronic resource] |
260 |
_bCurrent radiopharmaceuticals _cJul 2011 |
||
300 |
_a197-213 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAlpha Particles _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xradiotherapy |
650 | 0 | 4 | _aProtein Transport |
650 | 0 | 4 |
_aRadioimmunotherapy _xmethods |
650 | 0 | 4 |
_aRadioisotopes _xtherapeutic use |
650 | 0 | 4 |
_aRadiopharmaceuticals _xtherapeutic use |
700 | 1 | _aElgqvist, Jorgen | |
700 | 1 | _aWu, Anna M | |
773 | 0 |
_tCurrent radiopharmaceuticals _gvol. 4 _gno. 3 _gp. 197-213 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1874471011104030197 _zAvailable from publisher's website |
999 |
_c21421742 _d21421742 |